Directors Message Understanding Research
As scientists we’ve made it our life’s work to understand more. In this month’s newsletter you’ll read about Dr. Stephen Ferguson’s work on Huntington’s disease and three of our scientists who are working to change the sometimes fatal outcome of heart failure. Here at Robarts we’re finding ways to stop cancer cells, maintain healthy hearts, and keep brain cells alive. Through research we are striving to replace fear with hope. Best, |
Research Updates Protecting the brain from a deadly genetic disease |
Institute News New Dean for Schulich School of Medicine & Dentistry |
Donor Profile Continued support for Cancer research at Robarts
Fuller’s husband, Robert W. Fuller, died from cancer in 2002, and her gift is a reflection of her commitment to advance cancer research. Schild-Poulter holds the position of Fuller Scientist, which is funded by a previous donation from Marilynne Fuller. Schild-Poulter is investigating ways in which cells respond to DNA damage, providing hope for the development of targeted cancer drugs or anti-cancer combination therapies. Read More... |
Fundraising Priority The Robarts Fund
Robarts Research Institute takes an interdisciplinary approach to medical research with biologists and biomedical engineers, physicians and physicists, investigating better ways to diagnose, treat and ultimately prevent diseases such as Alzheimer’s, cancer, heart disease and stroke. For our scientists to continue to pursue cutting-edge clinical and basic research, Robarts is committed to raising $2.5 million over the next several years to establish The Robarts Fund – a fully expendable resource that will enable the Institute to address immediate priorities and respond financially to emerging opportunities. Read More... |
Marie Curie, physicist and chemist in the 1800’s, believed that, “Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less”. Curie was the first woman to receive a Nobel Prize, and through her work in radioactivity the world's first studies were conducted into the treatment of cancer using radioactive isotopes.
Marilynne Fuller has made a gift of approximately $50,000 to support the cancer research of Robarts scientist Caroline Schild-Poulter, PhD. 